The Role of Hyperbaric Oxygen Therapy (HBOT) in Hospitals & Medical Clinics
Hospitals and medical centres considering hyperbaric capability operate in a high-governance environment. Clinical HBOT is a clinician-led intervention in which the responsible healthcare team determines suitability, equipment, pressure, oxygen delivery, monitoring and the wider clinical pathway.
This must be kept distinct from Origin Oxygen products supplied for general wellbeing. Product classifications and intended uses can differ, and no chamber should be assumed to be a medical device or suitable for a clinical application without product-specific verification.
Safe integration therefore depends on clear governance, professional accountability and documented operating procedures. Clinical outcomes vary, and decisions about diagnosis, clinical management and suitability remain with appropriately qualified healthcare professionals.
Defining the Service Scope
Before a service is introduced, the organisation should define its purpose, referral criteria, leadership and boundaries. A clinical HBOT pathway requires formal professional oversight, whereas a general-wellbeing installation has a different role and should not be represented as providing clinical care.
Admission or participation criteria, consent, record keeping, monitoring and escalation arrangements should be documented. The organisation should also make clear which team is responsible for clinical screening, technical operation, emergency response and onward referral.
Equipment, Competence and Governance
Equipment suitability must be verified against the exact product’s regulatory status, technical specifications, manufacturer instructions and intended use. Service schedules, inspections and maintenance records should be maintained in line with those requirements.
Clinical and technical responsibilities should be allocated to people with the relevant competence. Staff training, handovers, emergency drills and communication procedures should be documented and kept current. General-wellbeing Origin products must not be presented as clinical HBOT equipment unless the specific product documentation supports that use.
Safety, Screening and Service Boundaries
Hyperbaric environments require structured safety management. Appropriate controls may include clinical screening, informed consent, in-session monitoring, fire and oxygen safety procedures, equipment checks, maintenance and transparent incident reporting.
The responsible team should also define how concerns are escalated and how responsibilities are divided between clinicians and technical operators. Records of equipment status, staff competence and safety events help the organisation confirm that the service remains aligned with its approved scope.
Clinical Research, Evidence and Product Status
Clinical research has examined HBOT in selected medical contexts, but studies can differ in equipment, pressure, oxygen concentration, protocol, patient population, concurrent care and professional supervision. These differences matter when interpreting evidence.
Published findings should not be used to imply that an Origin Oxygen product has been tested, approved or validated for the same clinical application. Research summaries should remain separate from product claims, and all product statements should be checked against verified certification, documentation and intended use.
FAQs
No. Suitability depends on the exact equipment, its verified regulatory status and intended use, and the organisation’s governance and safety requirements. Product status should be confirmed before any clinical role is considered.
Only with careful context. Research may involve different equipment and specialist clinical protocols. It should not be presented as evidence that a particular Origin Oxygen product will deliver the same clinical outcome.
A defined scope, appropriate leadership, equipment verification, trained staff, screening and consent processes, monitoring, maintenance, safety controls, emergency procedures, record keeping and clear referral or escalation routes.
Not unless the exact product’s certification, documentation and intended use support that description. General-wellbeing equipment and clinician-led clinical HBOT should be clearly distinguished in both operations and communications.
Conclusion
For hospitals and medical centres, hyperbaric capability requires clear governance, verified equipment status and competent professional oversight. Clinical HBOT and Origin Oxygen products supplied for general wellbeing should not be treated as interchangeable. Research findings must be interpreted in their original clinical context and not transferred automatically to a commercial product. Suitability and outcomes vary between individuals, and diagnosis and clinical decisions remain with appropriately qualified professionals. This information is general and does not replace clinical guidance.